Evidence map›Paper›PMID 35896188›Full record

SynthesisBMJ (Clinical research ed.)2022

Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves.

Benjamin Kye Jyn Tan, Ruobing Han, Joseph J Zhao, Nicole Kye Wen Tan, Emrick Sen Hui Quah, Claire Jing-Wen Tan, Yiong Huak Chan, Neville Wei Yang Teo, Tze Choong Charn, Anna See and 9 more

Erratum issued Registry-linked trialOpen access · bronzeAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMJ (Clinical research ed.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05947643 (Smell in COVID-19 and Efficacy of Nasal Theophylline 3), which is not on this map. Cited by 133 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed, 5 pooled it
26.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05947643 phase2completednot on this map

Smell in COVID-19 and Efficacy of Nasal Theophylline 3

TypeinterventionalSponsorWashington University School of MedicineRan2022 to 2025Enrolled77ConditionsCOVID-19Armstheophylline, Placebo
3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 5 syntheses or guidelines pooled it, 217 citations in OpenAlex.

  1. Pooled it
  2. Stroke Risk in Head and Neck Cancer: A Meta-analysis of Reconstructed Individual Patient Survival Data.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Limited observed efficacy of olfactory training in severe long-term post-COVID-19 syndrome: a prospective cohort study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  12. Unique and shared patterns of chemosensory dysfunction distinguish chronic COVID-19 and aspirin-exacerbated respiratory disease.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 4 countries.

Benjamin Kye Jyn TanYong Loo Lin School of Medicine, National University of Singapore, Singapore.ORCID 0000-0002-9411-6164
Ruobing HanYong Loo Lin School of Medicine, National University of Singapore, Singapore.ORCID 0000-0003-0643-374X
Joseph J ZhaoYong Loo Lin School of Medicine, National University of Singapore, Singapore.ORCID 0000-0002-2002-5390
Nicole Kye Wen TanYong Loo Lin School of Medicine, National University of Singapore, Singapore.ORCID 0000-0002-2597-9142
Emrick Sen Hui QuahYong Loo Lin School of Medicine, National University of Singapore, Singapore.ORCID 0000-0002-1629-6358
Claire Jing-Wen TanYong Loo Lin School of Medicine, National University of Singapore, Singapore.ORCID 0000-0003-4529-2978
Yiong Huak ChanBiostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.ORCID 0000-0002-5076-5269
Neville Wei Yang TeoSurgery Academic Clinical Program, SingHealth, Singapore.ORCID 0000-0001-6537-3308
Tze Choong CharnSurgery Academic Clinical Program, SingHealth, Singapore.ORCID 0000-0002-2040-2846
Anna SeeSurgery Academic Clinical Program, SingHealth, Singapore.ORCID 0000-0003-2126-4665
Shuhui XuSurgery Academic Clinical Program, SingHealth, Singapore.ORCID 0000-0001-5666-1551
Nikita ChapurinDepartment of Otorhinolaryngology-Head and Neck Surgery, Vanderbilt University Medical Centre, Nashville, TN, USA.ORCID 0000-0002-3744-0451
Rakesh K ChandraDepartment of Otorhinolaryngology-Head and Neck Surgery, Vanderbilt University Medical Centre, Nashville, TN, USA.ORCID 0000-0002-3612-0026
Naweed ChowdhuryDepartment of Otorhinolaryngology-Head and Neck Surgery, Vanderbilt University Medical Centre, Nashville, TN, USA.ORCID 0000-0001-9826-4917
Rafal ButowtDepartment of Molecular Cell Genetics, L Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.ORCID 0000-0001-9614-4022
Christopher S von BartheldDepartment of Physiology and Cell Biology, School of Medicine, University of Nevada, Reno, NV, USA.ORCID 0000-0003-2716-6601
B Nirmal KumarWigan and Leigh Teaching NHS Foundation Trust, Wrightington, UK.ORCID 0000-0003-1653-0754
Claire HopkinsDepartment of Otorhinolaryngology-Head and Neck Surgery, Guy's and St Thomas' Hospitals, London, UK.ORCID 0000-0003-3993-1569
Song Tar TohSurgery Academic Clinical Program, SingHealth, Singapore toh.song.tar@singhealth.com.sg.ORCID 0000-0003-2077-2457
National University of Singapore · SGSingHealth · SGVanderbilt University Medical Center · USEdge Hill University · GBNicolaus Copernicus University · PLSt Thomas' Hospital · GBUniversity of Nevada, Reno · US

Funding

Cell Biology of Signaling across MembranesP20GM103554 · NIGMS · UNIVERSITY OF NEVADA RENO · PI VON BARTHELD, CHRISTOPHER S · 2012 to 2016
$8.0M
NIGMS NIH HHS P20 GM103554
6 · The paper itself

Abstract

objectiveTo clarify in patients with covid-19 the recovery rate of smell and taste, proportion with persistent dysfunction of smell and taste, and prognostic factors associated with recovery of smell and taste.

designSystematic review and meta-analysis. DATA SOURCES: PubMed, Embase, Scopus, Cochrane Library, and medRxiv from inception to 3 October 2021. REVIEW

methodsTwo blinded reviewers selected observational studies of adults (≥18 years) with covid-19 related dysfunction of smell or taste. Descriptive prognosis studies with time-to-event curves and prognostic association studies of any prognostic factor were included. DATA EXTRACTION AND SYNTHESIS: Two reviewers extracted data, evaluated study bias using QUIPS, and appraised evidence quality using GRADE, following PRISMA and MOOSE reporting guidelines. Using iterative numerical algorithms, time-to-event individual patient data (IPD) were reconstructed and pooled to retrieve distribution-free summary survival curves, with recovery rates reported at 30 day intervals for participants who remained alive. To estimate the proportion with persistent smell and taste dysfunction, cure fractions from Weibull non-mixture cure models of plateaued survival curves were logit transformed and pooled in a two stage meta-analysis. Conventional aggregate data meta-analysis was performed to explore unadjusted associations of prognostic factors with recovery.

main outcome measuresThe primary outcomes were the proportions of patients remaining with smell or taste dysfunction. Secondary outcomes were the odds ratios of prognostic variables associated with recovery of smell and taste.

results18 studies (3699 patients) from 4180 records were included in reconstructed IPD meta-analyses. Risk of bias was low to moderate; conclusions remained unaltered after exclusion of four high risk studies. Evidence quality was moderate to high. Based on parametric cure modelling, persistent self-reported smell and taste dysfunction could develop in an estimated 5.6% (95% confidence interval 2.7% to 11.0%, I

conclusionsA substantial proportion of patients with covid-19 might develop long lasting change in their sense of smell or taste. This could contribute to the growing burden of long covid. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42021283922.

Indexed as

COVID-19Olfaction DisordersFemaleHumansPost-Acute COVID-19 SyndromePrognosisSmellTasteTaste Disorders

Identifiers

PMID35896188
PMCPMC9326326
OpenAlexW4288074746

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.